“…2.Promote MTC apoptosis and enhance cancer cell sensitivity to ionizing radiation [ 59 , 62 , 65 , 68 , 69 , 139 , 140 ] | MDM4 | PTC, ATC | p53 | | 1.Downregulate with tumor progression in PTC and associate with PTC non-multifocality 2. Increase survival of mice with wild-type p53 when reduced in ATC | [ [63] , [64] , [65] ] |
Praja2 | PTC, ATC | PKA | cAMP/Praja2/PKA | 1.Overexpressed in PTC, Activate cAMP signaling pathway, promote proliferation 2.Low expression in ATC, can be used to monitor the degree of tumor malignancy | [ 124 ] |
Rbx1 | PTC, ATC | SMAR1, NRF2 | Rbx1/SMAR1/PKM1 | promote invasion, migration, promote carcinogenic potential, inhibit autophagy | [ 130 , 152 ] |
RNF150 | PTC | ASK1 | RNF150/ASK1/p38 | Downregulated in PTC, inhibit MAPK signaling pathway, inhibit proliferation, migration | [ 129 ] |
SH3RF3 | PTC | | miR-192-5p/SH3RF3 | Promote invasion, migration | [ 118 ] |
SKP2 | PTC, FTC, ATC | p27, PHLPP1 | 1.SKP2/PHLPP1/AKT 2. SKP2/p27 | Promote proliferation, inhibit apoptosis and autophagy | [ 55 , 97 , 114 ] |
…”